Skip to content

Quick ratio at other companies

MYR Group logo
MYR GroupMYRG
1.3×0.0×
SSR Mining logo
SSR MiningSSRM
4.9×+2.6×
Repligen logo
RepligenRGEN
7.8×+2.0×
Karman Holdings Inc. logo
Karman Holdings Inc.KRMN
3.4×+0.2×
Lamb Weston logo
Lamb WestonLW
0.7×+0.1×
Evolution Metals & Technologies Corp.
 logo
Evolution Metals & Technologies Corp. EMAT
0.1×+0.1×

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Calculated from Generate Biomedicines, Inc. ’s reported figures.

Based on the most recent quarter.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's quick ratio?
Generate Biomedicines, Inc. (GENB) reported quick ratio of 9.2× in Q1 2026.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.